Cysteine-rich protein 1 is regulated by transforming growth factor-β1 and expressed in lung fibrosis

Journal of Cellular Physiology

Volumn 227, Issue 6, 2012, Pages 2605-2612

  Järvinen, Päivi M ^a   Myllärniemi, Marjukka ^b   Liu, Hester ^c   Moore, Henna M ^a   Leppäranta, Outi ^b   Salmenkivi, Kaisa ^b   Koli, Katri ^a   Latonen, Leena ^a,d   Band, Arja M ^a   Laiho, Marikki ^a,c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; CYCLOHEXIMIDE; CYSTEINE RICH PROTEIN 1; CYSTEINE RICH PROTEIN 61; MITOGEN ACTIVATED PROTEIN KINASE P38; SHORT HAIRPIN RNA; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; UO 126;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG FIBROSIS; MYOFIBROBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CARRIER PROTEINS; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL SHAPE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LIM DOMAIN PROTEINS; LUNG; MICE; MYOFIBROBLASTS; NIH 3T3 CELLS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; TIME FACTORS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION;

EID: 84863147021     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.23000     Document Type: Article

References (49)

1. American Thoracic Society. 2000. Idiopathic pulmonary fibrosis: Diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 161:646-664.
2. Band A, Laiho M. 2008. Proteasome in the control of TGF-β signaling during development and cancer. In: Jakowlew S, editor. Transforming growth factor-beta in cancer therapy. Totowa, NJ: Humana Press. pp 243-257.
3. Bergeron A, Soler P, Kambouchner M, Loiseau P, Milleron B, Valeyre D, Hance AJ, Tazi A. 2003. Cytokine profiles in idiopathic pulmonary fibrosis suggest an important role for TGF-beta and IL-10. Eur Respir J 22:69-76.
4. Chang DF, Belaguli NS, Iyer D, Roberts WB, Wu SP, Dong XR, Marx JG, Moore MS, Beckerle MC, Majesky MW, Schwartz RJ. 2003. Cysteine-rich LIM-only proteins CRP1 and CRP2 are potent smooth muscle differentiation cofactors. Dev Cell 4:107-118.
5. Chang DF, Belaguli NS, Chang J, Schwartz RJ. 2007. LIM-only protein, CRP2, switched on smooth muscle gene activity in adult cardiac myocytes. Proc Natl Acad Sci USA 104:157-162.
6. Derynck R, Akhurst RJ. 2007. Differentiation plasticity regulated by TGF-beta family proteins in development and disease. Nat Cell Biol 9:1000-1004.
7. Desmoulière A, Geinoz A, Gabbiani F, Gabbiani G. 1993. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 122:103-111.
8. Ding L, Wang Z, Yan J, Yang X, Liu A, Qiu W, Zhu J, Han J, Zhang H, Lin J, Cheng L, Qin X, Niu C, Yuan B, Wang X, Zhu C, Zhou Y, Li J, Song H, Huang C, Ye Q. 2009. Human four-and-a-half LIM family members suppress tumor cell growth through a TGF-beta-like signaling pathway. J Clin Invest 119:349-361.
9. Gharaee-Kermani M, Hu B, Phan SH, Gyetko MR. 2009. Recent advances in molecular targets and treatment of idiopathic pulmonary fibrosis: Focus on TGFbeta signaling and the myofibroblast. Curr Med Chem 16:1400-1417.
10. Hecker L, Vittal R, Jones T, Jagirdar R, Luckhardt TR, Horowitz JC, Pennathur S, Martinez FJ, Thannickal VJ. 2009. NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat Med 15:1077-1081.
11. Herrmann J, Borkham-Kamphorst E, Haas U, Van de Leur E, Fraga MF, Esteller M, Gressner AM, Weiskirchen R. 2006. The expression of CSRP2 encoding the LIM domain protein CRP2 is mediated by TGF-beta in smooth muscle and hepatic stellate cells. Biochem Biophys Res Commun 345:1526-1535.
12. Hinz B, Celetta G, Tomasek JJ, Gabbiani G, Chaponnier C. 2001. Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol Biol Cell 12:2730-2741.
13. Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat ML, Gabbiani G. 2007. The myofibroblast: One function, multiple origins. Am J Pathol 170:1807-1816.
14. Ikushima H, Miyazono K. 2010. TGFbeta signalling: A complex web in cancer progression. Nat Rev Cancer 10:415-424.
15. Kadrmas JL, Beckerle MC. 2004. The LIM domain: From the cytoskeleton to the nucleus. Nat Rev Mol Cell Biol 5:920-931.
16. Kapoun AM, Gaspar NJ, Wang Y, Damm D, Liu YW, O'young G, Quon D, Lam A, Munson K, Tran TT, Ma JY, Murphy A, Dugar S, Chakravarty S, Protter AA, Wen FQ, Liu X, Rennard SI, Higgins LS. 2006. Transforming growth factor-beta receptor type 1 (TGFbetaRI) kinase activity but not p38 activation is required for TGFbetaRI-induced myofibroblast differentiation and profibrotic gene expression. Mol Pharmacol 70:518-531.
17. Khalil N, O'Connor RN, Unruh HW, Warren PW, Flanders KC, Kemp A, Bereznay OH, Greenberg AH. 1991. Increased production and immunohistochemical localization of transforming growth factor-beta in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 5:155-162.
18. Khalil N, O'Connor RN, Flanders KC, Unruh H. 1996. TGF-beta 1, but not TGF-beta 2 or TGF-beta 3, is differentially present in epithelial cells of advanced pulmonary fibrosis: An immunohistochemical study. Am J Respir Cell Mol Biol 14:131-138.
19. Kim KK, Kugler MC, Wolters PJ, Robillard L, Galvez MG, Brumwell AN, Sheppard D, Chapman HA. 2006. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci USA 103:13180-13185.
20. King TE, Jr., Schwarz MI, Brown K, Tooze JA, Colby TV, Waldron JA, Jr., Flint A, Thurlbeck W, Cherniack RM. 2001. Idiopathic pulmonary fibrosis: Relationship between histopathologic features and mortality. Am J Respir Crit Care Med 164:1025-1032.
21. Kolosova I, Nethery D, Kern JA. 2011. Role of Smad2/3 and p38 MAP kinase in TGF-β1-induced epithelial-mesenchymal transition of pulmonary epithelial cells. J Cell Physiol 226:1248-1254.
22. Kulkarni AA, Thatcher TH, Olsen KC, Maggirwar SB, Phipps RP, Sime PJ. 2011. PPAR-γ ligands repress TGFβ-induced myofibroblast differentiation by targeting the PI3K/Akt pathway: Implications for therapy of fibrosis. PLoS One 6:e15909.
23. Larsson O, Diebold D, Fan D, Peterson M, Nho RS, Bitterman PB, Henke CA. 2008. Fibrotic myofibroblasts manifest genome-wide derangements of translational control. PLoS ONE 3:e3220.
24. Latonen L, Järvinen PM, Laiho M. 2008. Cytoskeleton-interacting LIM-domain protein CRP1 suppresses cell proliferation and protects from stress-induced cell death. Exp Cell Res 314:738-747.
25. Latonen L, Järvinen PM, Suomela S, Moore HM, Saarialho-Kere U, Laiho M. 2010. Ultraviolet B radiation regulates cysteine-rich protein 1 in human keratinocytes. Photodermatol Photoimmunol Photomed 26:70-77.
26. Lilly B, Clark KA, Yoshigi M, Pronovost S, Wu ML, Periasamy M, Chi M, Paul RJ, Yet SF, Beckerle MC. 2010. Loss of the serum response factor cofactor, cysteine-rich protein 1, attenuates neointima formation in the mouse. Arterioscler Thromb Vasc Biol 30:694-701.
27. Lin DW, Chang IC, Tseng A, Wu ML, Chen CH, Patenaude CA, Layne MD, Yet SF. 2008. Transforming growth factor beta up-regulates cysteine-rich protein 2 in vascular smooth muscle cells via activating transcription factor 2. J Biol Chem 283:15003-15014.
28. Liu X, Kelm RJ, Jr., Strauch AR. 2009. Transforming growth factor beta1-mediated activation of the smooth muscle alpha-actin gene in human pulmonary myofibroblasts is inhibited by tumor necrosis factor-alpha via mitogen-activated protein kinase kinase 1-dependent induction of the Egr-1 transcriptional repressor. Mol Biol Cell 20:2174-2185.
29. Lopez-Casillas F, Riquelme C, Perez-Kato Y, Ponce-Castaneda MV, Osses N, Esparza-Lopez J, Gonzalez-Nunez G, Cabello-Verrugio C, Mendoza V, Troncoso V, Brandan E. 2003. Betaglycan expression is transcriptionally up-regulated during skeletal muscle differentiation. Cloning of murine betaglycan gene promoter and its modulation by MyoD, retinoic acid, and transforming growth factor-beta. J Biol Chem 278:382-390.
30. Miyasaka KY, Kida YS, Sato T, Minami M, Ogura T. 2007. Csrp1 regulates dynamic cell movements of the mesendoderm and cardiac mesoderm through interactions with Dishevelled and Diversin. Proc Natl Acad Sci USA 104:11274-11279.
31. Mori M, Nakagami H, Koibuchi N, Miura K, Takami Y, Koriyama H, Hayashi H, Sabe H, Mochizuki N, Morishita R, Kaneda Y. 2009. Zyxin mediates actin fiber reorganization in epithelial-mesenchymal transition and contributes to endocardial morphogenesis. Mol Biol Cell 20:3115-3124.
32. Myllärniemi M, Vuorinen K, Pulkkinen V, Kankaanranta H, Aine T, Salmenkivi K, Keski-Oja J, Koli K, Kinnula V. 2008. Gremlin localization and expression levels partially differentiate idiopathic interstitial pneumonia severity and subtype. J Pathol 214:456-463.
33. Rahimi RA, Leof EB. 2007. TGF-beta signaling: A tale of two responses. J Cell Biochem 102:593-608.
34. Saeki N, Kim DH, Usui T, Aoyagi K, Tatsuta T, Aoki K, Yanagihara K, Tamura M, Mizushima H, Sakamoto H, Ogawa K, Ohki M, Shiroishi T, Yoshida T, Sasaki H. 2007. GASDERMIN, suppressed frequently in gastric cancer, is a target of LMO1 in TGF-beta-dependent apoptotic signalling. Oncogene 26:6488-6498.
35. Santander C, Brandan E. 2006. Betaglycan induces TGF-beta signaling in a ligand-independent manner, through activation of the p38 pathway. Cell Signal 18:1482-1491.
36. Scotton CJ, Chambers RC. 2007. Molecular targets in pulmonary fibrosis: The myofibroblast in focus. Chest 132:1311-1321.
37. Shibanuma M, Mashimo J, Kuroki T, Nose K. 1994. Characterization of the TGF-beta 1-inducible hic-5 gene that encodes a putative novel zinc finger protein and its possible involvement in cellular senescence. J Biol Chem 269:26767-26774.
38. Sime PJ, Xing Z, Graham FL, Csaky KG, Gauldie J. 1997. Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. J Clin Invest 100:768-776.
39. Sousa AM, Liu T, Guevara O, Stevens J, Fanburg BL, Gaestel M, Toksoz D, Kayyali US. 2007. Smooth muscle alpha-actin expression and myofibroblast differentiation by TGFbeta are dependent upon MK2. J Cell Biochem 100:1581-1592.
40. Tran TC, Singleton C, Fraley TS, Greenwood JA. 2005. Cysteine-rich protein 1 (CRP1) regulates actin filament bundling. BMC Cell Biol 6:45.
41. Wang H, Song K, Sponseller TL, Danielpour D. 2005. Novel function of androgen receptor-associated protein 55/Hic-5 as a negative regulator of Smad3 signaling. J Biol Chem 280:5154-5162.
42. Wang H, Song K, Krebs TL, Yang J, Danielpour D. 2008. Smad7 is inactivated through a direct physical interaction with the LIM protein Hic-5/ARA55. Oncogene 27:6791-6805.
43. Willis BC, Liebler JM, Luby-Phelps K, Nicholson AG, Crandall ED, du Bois RM, Borok Z. 2005. Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: Potential role in idiopathic pulmonary fibrosis. Am J Pathol 166:1321-1332.
44. Wynn TA. 2008. Cellular and molecular mechanisms of fibrosis. J Pathol 214:199-210.
45. Xaubet A, Marin-Arguedas A, Lario S, Ancochea J, Morell F, Ruiz-Manzano J, Rodriguez-Becerra E, Rodriguez-Arias JM, Inigo P, Sanz S, Campistol JM, Mullol J, Picado C. 2003. Transforming growth factor-beta1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 168:431-435.
46. Yoshida K, Kuwano K, Hagimoto N, Watanabe K, Matsuba T, Fujita M, Inoshima I, Hara N. 2002. MAP kinase activation and apoptosis in lung tissues from patients with idiopathic pulmonary fibrosis. J Pathol 198:388-396.
47. You HJ, Bruinsma MW, How T, Ostrander JH, Blobe GC. 2007. The type III TGF-beta receptor signals through both Smad3 and the p38 MAP kinase pathways to contribute to inhibition of cell proliferation. Carcinogenesis 28:2491-2500.
48. Yu L, Hébert MC, Zhang YE. 2002. TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses. EMBO J 21:3749-3759.
49. Zhang YE. 2009. Non-Smad pathways in TGF-beta signaling. Cell Res 19:128-139.